BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baytas SN, Linhardt RJ. Advances in the preparation and synthesis of heparin and related products. Drug Discov Today 2020;25:2095-109. [PMID: 32947045 DOI: 10.1016/j.drudis.2020.09.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang L, Zhang T, Lu H, Li S, Lv K, Tuffour A, Zhang L, Ding K, Li JP, Li H, Liu X. Heparin mimetics as potential intervention for COVID-19 and their bio-manufacturing. Synth Syst Biotechnol 2023;8:11-9. [PMID: 36313216 DOI: 10.1016/j.synbio.2022.10.002] [Reference Citation Analysis]
2 Zhang L, Liu Y, Xu Z, Hao T, Wang PG, Zhao W, Li T. Design and Synthesis of Neutralizable Fondaparinux. JACS Au 2022. [DOI: 10.1021/jacsau.2c00537] [Reference Citation Analysis]
3 Zang L, Zhu H, Wang K, Liu Y, Yu F, Zhao W. Not Just Anticoagulation—New and Old Applications of Heparin. Molecules 2022;27:6968. [DOI: 10.3390/molecules27206968] [Reference Citation Analysis]
4 Li Y, Lin Y, Jiang Y, Mehwish HM, Rajoka MSR, Zhao L. Expression and characterization of heparinase II with MBP tag from a novel strain, Raoultella NX-TZ-3-15. Arch Microbiol 2022;204:551. [PMID: 35951138 DOI: 10.1007/s00203-022-03158-4] [Reference Citation Analysis]
5 Wang P, Chi L, Zhang Z, Zhao H, Zhang F, Linhardt RJ. Heparin: An old drug for new clinical applications. Carbohydrate Polymers 2022. [DOI: 10.1016/j.carbpol.2022.119818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hu Y, Chai Q, Wang Y, Chen Y, Dong H, Shen J, Qi Y, Yu H, Wang F, Wen Q. Effects of Heat Stress and Exogenous Salicylic Acid on Secondary Metabolites Biosynthesis in Pleurotus ostreatus (Jacq.) P. Kumm. Life (Basel) 2022;12:915. [PMID: 35743946 DOI: 10.3390/life12060915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Grinkova AA, Ustyuzhanina NE, Nifantiev NE. Synthesis of Oligosaccharides Structurally Related to Hyaluronic Acid Fragments. Russ J Bioorg Chem 2022;48:191-220. [DOI: 10.1134/s1068162022020108] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Cao X, Du X, Jiao H, An Q, Chen R, Fang P, Wang J, Yu B. Carbohydrate-based drugs launched during 2000−2021. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.05.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Zhou Z, Zhang L, Wu X, Luo L, Wu J, Xu D, Wu M. Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114256] [Reference Citation Analysis]
10 Schulze M, Adigüzel S, Nickl P, Schmitt A, Dernedde J, Ballauff M, Haag R. A Simple and Robust Method to Prepare Polyelectrolyte Brushes on Polymer Surfaces. Adv Materials Inter 2022;9:2102005. [DOI: 10.1002/admi.202102005] [Reference Citation Analysis]
11 Zhang Y, Wang Y, Zhou Z, Wang P, Xi X, Hu S, Xu R, Du G, Li J, Chen J, Kang Z. Synthesis of bioengineered heparin by recombinant yeast Pichia pastoris. Green Chem . [DOI: 10.1039/d1gc04672a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhang G, Yang K, Wang L, Cheng Y, Liu C. Facile chemoenzymatic synthesis of unmodified anticoagulant ultra-low molecular weight heparin. Org Biomol Chem 2022;20:8323-8330. [DOI: 10.1039/d2ob01221a] [Reference Citation Analysis]
13 Karlsson R, Chopra P, Joshi A, Yang Z, Vakhrushev SY, Clausen TM, Painter CD, Szekeres GP, Chen YH, Sandoval DR, Hansen L, Esko JD, Pagel K, Dyer DP, Turnbull JE, Clausen H, Boons GJ, Miller RL. Dissecting structure-function of 3-O-sulfated heparin and engineered heparan sulfates. Sci Adv 2021;7:eabl6026. [PMID: 34936441 DOI: 10.1126/sciadv.abl6026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
14 Laner-Plamberger S, Oeller M, Rohde E, Schallmoser K, Strunk D. Heparin and Derivatives for Advanced Cell Therapies. Int J Mol Sci 2021;22:12041. [PMID: 34769471 DOI: 10.3390/ijms222112041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Zappe A, Miller RL, Struwe WB, Pagel K. State-of-the-art glycosaminoglycan characterization. Mass Spectrom Rev 2021. [PMID: 34608657 DOI: 10.1002/mas.21737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Baytas SN, Varghese SS, Jin W, Yu Y, He P, Douaisi M, Zhang F, Brodfuehrer P, Xia K, Dordick JS, Linhardt RJ. Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin. J Med Chem 2021;64:2242-53. [PMID: 33586962 DOI: 10.1021/acs.jmedchem.0c02019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Yu M, Zhang T, Zhang W, Sun Q, Li H, Li JP. Elucidating the Interactions Between Heparin/Heparan Sulfate and SARS-CoV-2-Related Proteins-An Important Strategy for Developing Novel Therapeutics for the COVID-19 Pandemic. Front Mol Biosci 2020;7:628551. [PMID: 33569392 DOI: 10.3389/fmolb.2020.628551] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 22.0] [Reference Citation Analysis]
18 Dubey SK, Parab S, Dabholkar N, Agrawal M, Singhvi G, Alexander A, Bapat RA, Kesharwani P. Oral peptide delivery: challenges and the way ahead. Drug Discov Today 2021;26:931-50. [PMID: 33444788 DOI: 10.1016/j.drudis.2021.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
19 Shi C, Tingting W, Li JP, Sullivan MA, Wang C, Wang H, Deng B, Zhang Y. Comprehensive Landscape of Heparin Therapy for COVID-19. Carbohydr Polym 2021;254:117232. [PMID: 33357843 DOI: 10.1016/j.carbpol.2020.117232] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]